🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the pharmacokinetics of vildagliptin and its metab...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-07
Trial ID
NCT00567047
Treatments Being Tested
The purpose of this study was to determine whether the initiation of a vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03-30
Trial ID
NCT01528254
Treatments Being Tested
Phase IIIb, randomized, multicenter, double-blind, prospective study to eva...
Status
Completed
Location
Centro de Investigación y Avances Médicos Especializados
Start Date
2023-03-21
Trial ID
NCT04841096
The present study is a phase I, single-centre, double-blind, randomized, cr...
Status
Completed
Location
Diabeteszentrum Bad Lauterberg
Start Date
2011-11
Trial ID
NCT02749032
Treatments Being Tested
Vildagliptin, an antidiabetic drug that inhibits the dipeptidyl peptidase- ...
Status
Withdrawn
Location
Faculty of Medicine
Start Date
2020-05-01
Trial ID
NCT04410341
Treatments Being Tested
This is an open-labeled, randomized, multicenter, prospective, parallel gro...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01541956
Treatments Being Tested
We compared the cardioprotective effects of empagliflozin, an SGLT2 inhibit...
Status
Completed
Location
Rehab Hussein Werida
Start Date
2023-08-10
Trial ID
NCT06313008
Treatments Being Tested
Men and post- or induced menopausal women with ER\[+\] and/or PgR\[+\], HER...
Status
Completed
Location
Hospital General Universitario de Alicante
Start Date
2020-10-23
Trial ID
NCT04300790
Treatments Being Tested
The purpose of this study is to determine whether monotherapy with Vildagli...
Status
Completed
Location
Medical University of Vienna
Start Date
2009-09
Trial ID
NCT00980356
Treatments Being Tested
This study is designed to evaluate the efficacy, safety and tolerability of...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-08
Trial ID
NCT00368134
Treatments Being Tested